We are actively developing, and in 2024 we plan to launch four more plantations in Denmark and Portugal with the support of GPT Group and Prologis, Inc investment funds. We produce medicinal cannabis for pharmaceutical companies. In 2020, we developed a cultivation technology that allows us to harvest crops every 11 days. In early 2021, the company's management made the decision to create an investment proposal based on this technology. In 2022, IVEY11 LTD was established, introducing its cultivation technology and investment proposal to the general public. IVEY11 LTD manufactures its product for pharmaceutical companies specializing in the production of hemp pharmaceuticals, such as Nabilone - Cesament, Dronabinol - Marinol, Nabiximols, Epidiolex, and so on. These drugs are in great demand in the global pharmaceutical market. Before being sold, the harvested crop from IVEY11 LTD undergoes necessary processing in the laboratory and is transformed into distillate, which is then transported, following legal norms and applicable permits, to pharmaceutical companies for further processing. Daily interest is paid from the savings account of IVEY11 LTD, which is specially organized to increase the attractiveness of investment offer. The costs of payments are compensated after each sold batch of products. A British company that has been growing and selling medical cannabis since 2018. The company now operates nine plantations around the world and has big plans for the future. This is not just a way to invest in the field of organic herbal components but also a way to help popularize cryptocurrency as an ecological sector by taking this tool into various business spheres, including the medical and healthcare sectors.

Main info

Hosting info

Withdraw types

Ratings and monitors

Remarks